Interleukin-2 gene
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-2 gene, covering 2013-05-30 to 2013-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer [Phase 2]